Products for Research Use Only
RegisterLogin

Sovipostobart

CAT: 0804-HY-P990080-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P990080-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Sovipostobart is an immunoglobulin G1-kappa, anti-CTLA-4 human monoclonal antibody with cleavable prodomain. Sovipostobart is an immunostimulant and antineoplastic[1].
CAS Number
2649371-19-5
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
CTLA-4
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sovipostobart.html
Purity
96.528
Solubility
10 mM in DMSO
Smiles
[Sovipostobart]
Molecular Weight
(153.531 kDa)
Precautions
H302, H315, H319, H335
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 36, No. 4, 2022.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
T81124-01Sovipostobart
GTR18333553-01Sovipostobart Antibody
DHD17228Research Grade Sovipostobart
E55B1042Sovipostobart (Reference antibody)
ICH5879-25mgSovipostobart Biosimilar - Research Grade
GTR18780750-01(Sovipostobart) Biosimilar Reference Antibody
DHD17232Research Grade Sovipostobart Beta
A138200Sovipostobart Biosimilar (Monoclonal, IgG1)
GTR18695985-01Sovipostobart Human Monoclonal Antibody
RA0173-01Sovipostobart (Biosimilar Reference Antibody) (CTLA4)

Popular Products